Six patients who were treated with corticotropin or high dose adrenal steroid therapy for exacerbations of multiple sclerosis (MS) developed serious and perplexing pulmonary infections. Cavitation and multilobular pneumonia were common. Sputum was scant and physical signs of lung involvement were frequently minimal at the onset. The early signs of the infection may have been masked by the anti-inflammatory drugs, leading to a delay in treatment. Conventional bacterial pathogens were implicated in only a few of the patients, and the response to anti-bacterial therapy was slow and unimpressive. Two patients died of their infection.
Since corticotropin or adrenal steroid therapy do not alter impressively the course of MS, our experience suggests greater caution in selecting patients with this disease for treatment with corticotropin or adrenal steroids.
Sexauer JM, Fekety FR. Pulmonary Infections Complicating Treatment of Multiple Sclerosis: Occurrence With Administration of Corticotropin or Adrenal Steroids. Arch Neurol. 1974;30(4):293–295. doi:10.1001/archneur.1974.00490340021003
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: